The study is a prospective clinical cohort study of consecutive patients hospitalized at all hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The investigators aim to examine if continuous ECG monitoring can be used to understand the contribution of COVID-19 infection in the acute phase to the development of cardiac arrhythmias, especially focusing on cardiovascular outcomes. In all patients included, the investigators aim to examine if continuous ECG monitoring - alone and in combination with biomarkers - can be used to detect early signs of cardiac complications and predict long-term risk of cardiovascular morbidity and mortality following COVID-19 infection.
Device: C3+ Holter Monitor
ECG monitoring
Inclusion Criteria:
- All patients hospitalized at hospitals of greater Copenhagen area and Zealand with a
laboratory confirmed diagnosis of COVID-19 > 18 years of age.
Exclusion Criteria:
- Persons not able to cooperate
- Persons unable to understand and sign "informed consent"
Department of Cardiology, Herlev & Gentofte Hospital
Copenhagen, Hellerup, Denmark